Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study
OPEN Journal of hepatology | 13 Mar 2017
O Detry, M Vandermeulen, MH Delbouille, J Somja, N Bletard, A Briquet, C Lechanteur, O Giet, E Baudoux, M Hannon, F Baron and Y Beguin
Mesenchymal stromal cell (MSC) infusion could be a mean to establish tolerance in solid organ recipients. The aim of this prospective, controlled, phase-1 study was to evaluate the feasibility, safety and tolerability of a single infusion of MSCs in liver transplant recipients.
* Data courtesy of Altmetric.com